STOCK TITAN
  1. Home
  2. Sec-filings
  3. JBIO
  4. [EFFECT] Jade Biosciences, Inc. SEC Filing

[EFFECT] Jade Biosciences, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 19, 2025 4:00 P.M.
Form: S-1
CIK: 0001798749
Company Name: Jade Biosciences, Inc.
File Number: 333-291541

Source: View Original Filing on SEC EDGAR

Jade Biosciences Inc

NASDAQ:JBIO

View JBIO Stock Overview →

JBIO Rankings

#3150 Ranked by Market Cap
N/A Ranked by Dividends

JBIO Latest News

Mar 6, 2026
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb 11, 2026
Jade Biosciences to Participate in Upcoming Conferences
Jan 5, 2026
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
Dec 15, 2025
Jade Biosciences Announces $45 Million Private Placement
Nov 13, 2025
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

JBIO Latest SEC Filings

Mar 6, 2026
[POS EX] Jade Biosciences, Inc. SEC Filing
Mar 6, 2026
[POS EX] Jade Biosciences, Inc. SEC Filing
Mar 6, 2026
[424B3] Jade Biosciences, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Mar 6, 2026
[424B3] Jade Biosciences, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Mar 6, 2026
[10-K] Jade Biosciences, Inc. Files Annual Report

JBIO Stock Data

683.50M
48.11M
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM